CD274 and cancer: Thyroid irAEs in cancer patients treated with PDL1 inhibitors were characterized as new-onset hypothyroidism, thyrotoxicosis, and worsening of pre-existing hypothyroidism in a study conducted at the Mayo Clinic in Rochester, Minnesota.